Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

PROSTATE CANCER

IBD as a risk factor for prostate cancer: what is the link?

Chronic inflammation in the prostate is a suspected risk factor for prostate cancer. Burns and colleagues implicate chronic inflammation in prostate cancer development, albeit from an unexpected source — the gastrointestinal tract. This new study implicates a history of inflammatory bowel disease with an increased risk of a prostate cancer diagnosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Potential mechanisms underpinning a causal association between IBD and prostate cancer.

References

  1. Sfanos, K. S. et al. The inflammatory microenvironment and microbiome in prostate cancer development. Nat. Rev. Urol. 15, 11–24 (2018).

    Article  Google Scholar 

  2. van Leenders, G. J. et al. Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. Am. J. Pathol. 162, 1529–1537 (2003).

    Article  Google Scholar 

  3. Burns, J. A. et al. Inflammatory bowel disease and the risk of prostate cancer. Eur. Urol. https://doi.org/10.1016/j.eururo.2018.11.039 (2018).

    Article  PubMed  Google Scholar 

  4. Vighi, G. et al. Allergy and the gastrointestinal system. Clin. Exp. Immunol. 153 (Suppl. 1), 3–6 (2008).

    Article  CAS  Google Scholar 

  5. Pedersen, N. et al. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am. J. Gastroenterol. 105, 1480–1487 (2010).

    Article  Google Scholar 

  6. Vrakas, S. et al. Intestinal bacteria composition and translocation of bacteria in inflammatory bowel disease. PLOS ONE 12, e0170034 (2017).

    Article  Google Scholar 

  7. Malykhina, A. P. et al. Do the urinary bladder and large bowel interact, in sickness or in health? ICI-RS 2011. Neurourol. Urodyn. 31, 352–358 (2012).

    Article  Google Scholar 

  8. Bullones Rodriguez, M. A., Afari, N. & Buchwald, D. S. Evidence for overlap between urological and nonurological unexplained clinical conditions. J. Urol. 189 (Suppl. 1), 66–74 (2013).

    Google Scholar 

  9. Chung, S.-D., Keller, J. J. & Lin, H.-C. A case–control study of chronic prostatitis/chronic pelvic pain syndrome and colorectal cancer. BJU Int. 110, 550–554 (2012).

    Article  Google Scholar 

  10. Varda, B. K. et al. Urolithiasis and urinary tract infection among patients with inflammatory bowel disease: a review of US emergency department visits between 2006 and 2009. Urology 85, 764–770 (2015).

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank the Prostate Cancer Foundation (PCF) and the Department of Defense Prostate Cancer Research Program (PCRP) for ongoing research support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karen S. Sfanos.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sfanos, K.S., Joshu, C.E. IBD as a risk factor for prostate cancer: what is the link?. Nat Rev Urol 16, 271–272 (2019). https://doi.org/10.1038/s41585-019-0157-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41585-019-0157-7

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing